Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2022-01-27 Purchase |
2022-01-31 4:00 pm |
Oncternal Therapeutics Inc. | ONCT | BREITMEYER JAMES B Chief Executive Officer |
25,000 | $1.6832 | $42,080 | 437,919 (Indirect Direct) |
View |
| 2021-06-30 Sale |
2021-07-02 5:01 pm |
Oncternal Therapeutics Inc. | ONCT | HALE DAVID F Director |
3,669 | $4.75 | $17,428 | 731,498 (Indirect) |
View |
| 2021-06-11 Purchase |
2021-06-15 6:00 pm |
Oncternal Therapeutics Inc. | ONCT | Leavitt Chase C. General Counsel/Secretary |
1,500 | $5.45 | $8,175 | 1,500 (Direct) |
View |
| 2020-09-01 Purchase |
2020-09-02 4:53 pm |
Oncternal Therapeutics Inc. | ONCT | CARTER MICHAEL G Director |
71,429 | $2.1 | $150,001 | 71,947 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2022-01-20 Option Award |
2022-01-24 4:14 pm |
N/A 2032-01-20 |
Oncternal Therapeutics Inc. | ONCT | BREITMEYER JAMES B Chief Executive Officer |
802,000 | $0 | 802,000 (Direct) |
View |
| 2022-01-20 Option Award |
2022-01-24 4:00 pm |
N/A 2032-01-20 |
Oncternal Therapeutics Inc. | ONCT | Yazji Salim Chief Medical Officer |
92,075 | $0 | 92,075 (Direct) |
View |
| 2022-01-20 Option Award |
2022-01-24 4:00 pm |
N/A 2032-01-20 |
Oncternal Therapeutics Inc. | ONCT | VINCENT RICHARD G Chief Financial Officer |
109,579 | $0 | 109,579 (Direct) |
View |
| 2022-01-20 Option Award |
2022-01-24 4:00 pm |
N/A 2032-01-20 |
Oncternal Therapeutics Inc. | ONCT | Leavitt Chase C. General Counsel/Secretary |
55,519 | $0 | 55,519 (Direct) |
View |
| 2022-01-20 Option Award |
2022-01-24 4:00 pm |
N/A 2032-01-20 |
Oncternal Therapeutics Inc. | ONCT | Kaufmann Gunnar F. Chief Scientific Officer |
162,457 | $0 | 162,457 (Direct) |
View |
| 2022-01-20 Option Award |
2022-01-24 4:00 pm |
N/A 2032-01-20 |
Oncternal Therapeutics Inc. | ONCT | Krishnan Rajesh Chief Technology Officer |
177,050 | $0 | 177,050 (Direct) |
View |
| 2022-01-03 Option Award |
2022-01-05 7:00 pm |
N/A N/A |
Oncternal Therapeutics Inc. | ONCT | Krishnan Rajesh Chief Technology Officer |
29,867 | $0 | 29,867 (Direct) |
View |
| 2022-01-03 Option Award |
2022-01-05 7:00 pm |
N/A N/A |
Oncternal Therapeutics Inc. | ONCT | Yazji Salim Chief Medical Officer |
57,137 | $0 | 57,137 (Direct) |
View |
| 2022-01-03 Option Award |
2022-01-05 7:00 pm |
N/A N/A |
Oncternal Therapeutics Inc. | ONCT | BREITMEYER JAMES B Chief Executive Officer |
135,350 | $0 | 413,219 (Direct) |
View |
| 2022-01-03 Option Award |
2022-01-05 7:00 pm |
N/A N/A |
Oncternal Therapeutics Inc. | ONCT | Leavitt Chase C. General Counsel/Secretary |
29,867 | $0 | 31,367 (Direct) |
View |
| 2022-01-03 Option Award |
2022-01-05 7:00 pm |
N/A N/A |
Oncternal Therapeutics Inc. | ONCT | Kaufmann Gunnar F. Chief Scientific Officer |
29,867 | $0 | 29,867 (Direct) |
View |
| 2022-01-03 Option Award |
2022-01-05 7:00 pm |
N/A N/A |
Oncternal Therapeutics Inc. | ONCT | VINCENT RICHARD G Chief Financial Officer |
29,867 | $0 | 77,022 (Direct) |
View |
| 2021-05-25 Option Award |
2021-05-27 6:12 pm |
N/A 2031-05-25 |
Oncternal Therapeutics Inc. | ONCT | Wills Robert James Director |
25,000 | $0 | 25,000 (Direct) |
View |
| 2021-05-25 Option Award |
2021-05-27 6:09 pm |
N/A 2031-05-25 |
Oncternal Therapeutics Inc. | ONCT | KISNER DANIEL L Director |
25,000 | $0 | 25,000 (Direct) |
View |
Ownership |
2021-05-27 6:06 pm |
N/A 2029-08-12 |
Oncternal Therapeutics Inc. | ONCT | Krishnan Rajesh Chief Technology Officer |
0 | $0 | 287,470 (Direct) |
View |
| 2021-05-25 Option Award |
2021-05-27 6:06 pm |
N/A 2031-05-25 |
Oncternal Therapeutics Inc. | ONCT | CARTER MICHAEL G Director |
25,000 | $0 | 25,000 (Direct) |
View |
| 2021-05-25 Option Award |
2021-05-27 6:06 pm |
N/A 2031-05-25 |
Oncternal Therapeutics Inc. | ONCT | THEUER CHARLES Director |
25,000 | $0 | 25,000 (Direct) |
View |
| 2021-05-25 Option Award |
2021-05-27 6:06 pm |
N/A 2031-05-25 |
Oncternal Therapeutics Inc. | ONCT | Chen Jinzhu PhD Director |
50,000 | $0 | 50,000 (Direct) |
View |
Ownership |
2021-05-27 6:06 pm |
N/A 2031-04-12 |
Oncternal Therapeutics Inc. | ONCT | Leavitt Chase C. General Counsel/Secretary |
0 | $0 | 300,000 (Direct) |
View |
| 2021-05-25 Option Award |
2021-05-27 6:06 pm |
N/A 2031-05-25 |
Oncternal Therapeutics Inc. | ONCT | Nakanishi Xin Director |
25,000 | $0 | 25,000 (Direct) |
View |
| 2021-05-25 Option Award |
2021-05-27 6:06 pm |
N/A 2031-05-25 |
Oncternal Therapeutics Inc. | ONCT | HALE DAVID F Director |
37,500 | $0 | 37,500 (Direct) |
View |
Ownership |
2021-05-27 6:06 pm |
N/A 2031-05-17 |
Oncternal Therapeutics Inc. | ONCT | Yazji Salim Chief Medical Officer |
0 | $0 | 425,000 (Direct) |
View |
| 2021-05-25 Option Award |
2021-05-27 6:05 pm |
N/A 2031-05-25 |
Oncternal Therapeutics Inc. | ONCT | LARUE WILLIAM R Director |
25,000 | $0 | 25,000 (Direct) |
View |
| 2021-05-25 Option Award |
2021-05-27 6:05 pm |
N/A 2031-05-25 |
Oncternal Therapeutics Inc. | ONCT | MAZANET ROSEMARY Director |
25,000 | $0 | 25,000 (Direct) |
View |
| 2021-03-18 Option Award |
2021-03-22 4:00 pm |
N/A 2028-11-14 |
Oncternal Therapeutics Inc. | ONCT | BREITMEYER JAMES B Chief Executive Officer |
63,295 | $0 | 105,492 (Direct) |
View |
| 2021-01-27 Option Award |
2021-02-23 8:12 pm |
N/A 2031-01-27 |
Oncternal Therapeutics Inc. | ONCT | BREITMEYER JAMES B Chief Executive Officer |
9,000 | $0 | 9,000 (Indirect) |
View |
| 2021-02-11 Option Award |
2021-02-16 6:01 pm |
N/A 2031-02-11 |
Oncternal Therapeutics Inc. | ONCT | MAZANET ROSEMARY Director |
20,000 | $0 | 20,000 (Direct) |
View |
| 2021-02-11 Option Award |
2021-02-16 6:01 pm |
N/A 2031-02-11 |
Oncternal Therapeutics Inc. | ONCT | BILINSKY IGOR Chief Business Officer |
130,000 | $0 | 130,000 (Direct) |
View |
| 2021-02-11 Option Award |
2021-02-16 6:00 pm |
N/A 2031-02-11 |
Oncternal Therapeutics Inc. | ONCT | Kaufmann Gunnar F. Chief Scientific Officer |
253,000 | $0 | 253,000 (Direct) |
View |
| 2021-02-11 Option Award |
2021-02-16 6:00 pm |
N/A 2031-02-11 |
Oncternal Therapeutics Inc. | ONCT | BREITMEYER JAMES B Chief Executive Officer |
750,000 | $0 | 750,000 (Direct) |
View |
| 2021-02-11 Option Award |
2021-02-16 6:00 pm |
N/A 2031-02-11 |
Oncternal Therapeutics Inc. | ONCT | VINCENT RICHARD G Chief Financial Officer |
280,000 | $0 | 280,000 (Direct) |
View |
| 2021-01-27 Option Award |
2021-01-28 8:00 pm |
N/A 2031-01-27 |
Oncternal Therapeutics Inc. | ONCT | MAZANET ROSEMARY Director |
30,000 | $0 | 30,000 (Direct) |
View |
| 2020-06-11 Option Award(A) |
2020-07-31 9:06 pm |
N/A 2030-06-11 |
Oncternal Therapeutics Inc. | ONCT | THEUER CHARLES Director |
15,000 | $0 | 15,000 (Direct) |
View |
| 2020-06-11 Option Award(A) |
2020-07-31 9:06 pm |
N/A 2029-06-11 |
Oncternal Therapeutics Inc. | ONCT | LARUE WILLIAM R Director |
15,000 | $0 | 15,000 (Direct) |
View |